Trial intelligence / Profile preview

COMET-PCOS: OCP vs Metformin in PCOS

NCT03229057Phase 3Completed

Start
Jan 2018
Primary completion
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metformin, ethinyl estradiol + desogestrel in polycystic ovary syndrome (PCOS). Started Jan 2018; status: completed.

02

Drugs

metforminethinyl estradiol + desogestrel
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT03229057.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03229057.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call